The specific functions of glycans in a given biological process or pathogenic condition depend on their specific molecular compositions and structures. Accurate and quantitative measurements of glycomics profiles can greatly improve our understanding of the significant roles that glycans play in many common health problems and diseases. Despite technological advancements that have made mass spectrometry (MS) an essential tool for biomolecule analysis, unequivocal identification and structural characterization of glycans in complex biomatrix still remains to be fundamentally challenging tasks primary due to the extremely complex structures and the labile nature of glycans. The primary goal of this project is to develop a new ion mobility spectrometry (IMS)/MS-based instrument platform capable of detecting large and labile intact glycans and elucidating their structures with a much improved sensitivity and resolution. The new analytical platform will integrate a sub-ambient pressure ionization with nanoelectrospray (SPIN) source, a cyclotron IMS based on the structures for lossless Ion manipulations (SLIM) technology with a highly sensitive time of flight (TOF) MS by using electrodynamic ion funnel interfaces to achieve more than an order of magnitude better sensitivity and resolution as compared to any analytical tools currently available for glycan analysis. The biomedical applications of the new SPIN/SLIM-based cyclotron IMS/TOF MS instrument will be demonstrated by analyzing glycans in different cell lines representing different breast cancer subtypes to achieve unambiguous and complete structural elucidation of glycan biomarkers. The resulting instrument platform is expected to have broad biomedical applications that require high sensitivity and high resolution structural characterization of intact glycans.

Public Health Relevance

Comprehensive analysis of glycans in biofluids can significantly improve our understanding of the structure diversity and the functions of individual glycans as changes in glycan structures and abundances or the appearance of new glycans are associated with a variety of pathological conditions, such as diabetes, cancers and infectious disease. The proposed research will build a new instrument platform to allow high sensitivity identification and high resolution structural characterization of glycans in complex biomatrix.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA199744-01
Application #
8982643
Study Section
Special Emphasis Panel (ZRG1-OBT-L (50))
Program Officer
Kagan, Jacob
Project Start
2015-08-24
Project End
2017-06-30
Budget Start
2015-08-24
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$303,272
Indirect Cost
$139,272
Name
Battelle Pacific Northwest Laboratories
Department
Type
DUNS #
032987476
City
Richland
State
WA
Country
United States
Zip Code
99352